Pitfalls associated with commonly used methods for pharmacoeconomic analyses.

Abstract

Demonstrating the economic value of treatment has become an important objective of many clinical trials. Awareness of the limitations of the methods used in pharmacoeconomic studies of infectious diseases will help in understanding why improved methods are needed to adequately describe the costs associated with infectious episodes. Current analyses… (More)

Topics

Cite this paper

@article{Klepser2002PitfallsAW, title={Pitfalls associated with commonly used methods for pharmacoeconomic analyses.}, author={Donald G. Klepser}, journal={Pharmacotherapy}, year={2002}, volume={22 2 Pt 2}, pages={35S-38S} }